Delivery Order SPE2DB22D1106-SPE2DB25FDTN6
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.74 firm fixed-price contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a pharmaceutical product. The contract has a ceiling value of $1,881.14 and a period of performance through March 31, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a pharmaceutical product, with a ceiling value of $1,051.36 and a completion date of November 27, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,577.04, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,019.01, is for the supply of QUILLIVANT XR ORAL SUSP 180ML 5MG/ML, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,206.68, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML. The contract has a firm fixed price of $2,178.19 and a completion date of June 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,855.07, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 24, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML. The contract has a firm fixed price, a ceiling value of $3,374.88, and a period of performance ending on July 3, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.82 firm fixed-price contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a prescription medication. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...